门诊抗抑郁药真实世界处方模式:一项横断面分析
Real-world antidepressant prescribing patterns in outpatient care: a cross-sectional analysis
伊朗Tabriz门诊抗抑郁药横断面分析显示,2022年3月至2023年3月共开出570,599张处方,覆盖291,089例患者,总体处方率约191.6/1000参保人。
- Article
- Open access
- Published: 05 October 2026
- Ehsan Aghajani1,2,
- Sohrab Gharakhanlou1,
- Mostafa Farahbakhsh1,2,
- Ali Fakhari1,2,
- Ali Azimian2,3,
- Mahsa Matinkia1,2 &
- …
- Mahdieh Taiyebkhosroshahi1
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Depression is a major global health concern, with rising prevalence across all populations and regions. Antidepressants are a cornerstone of treatment, yet their use varies widely depending on drug class, patient demographics, and prescriber characteristics. Understanding real-world prescribing patterns is essential for optimizing care and informing policy. In Iran, despite widespread use of antidepressants, large-scale, data-driven studies examining these trends remain limited. This study aims to analyze outpatient antidepressant prescription patterns in Tabriz, Iran, from March 2022 to March 2023. Data were obtained from two major national health insurance providers: the Social Security Organization (SSO) and the Iran Health Insurance Organization (IHIO). A total of 19 antidepressant medications were selected, and prescriptions were examined in relation to drug type, patient age and sex, and physician specialty. During the study period, 570,599 antidepressant prescriptions were issued to 291,089 unique patients, corresponding to an overall prescribing rate of approximately 191.6 per 1000 insured persons and an average of 1.96 prescriptions per patient. The majority of patients were female (67.5%) with a mean age of 47.5 years. Most prescriptions were for adults aged 19–59 (70%), followed by older adults (24.8%). Selective serotonin reuptake inhibitors (SSRIs) were the most commonly prescribed class (58.8%), particularly sertraline and fluoxetine. Tricyclic antidepressants (TCAs) accounted for 27.7%, with nortriptyline as the leading agent; notably, a substantial proportion of TCA prescriptions were dispensed at the 10-mg unit strength, below the WHO Defined Daily Dose for these agents; however, unit strength alone could not establish actual daily dose or treatment indication. Psychiatrists issued the highest proportion of prescriptions (28.9%), followed by general practitioners and other specialties (22.1%) and internists (20.7%). Psychiatrists also showed the highest prescribing intensity, with an average of 2.86 prescriptions per patient compared with an overall average of 1.96. Prescription coverage was primarily through the SSO (77.9%). Drug class was significantly associated with both sex and physician specialty, although the corresponding effect sizes were small (Cramér’s V = 0.048 and 0.129, respectively). Surgeons prescribed proportionally more TCAs, whereas psychiatrists prescribed relatively more SNRIs, NDRIs, SARIs, and TeCAs. SSRIs have emerged as the most frequently prescribed class of antidepressants, which aligns with global preferences for these medications. Nonetheless, tricyclic antidepressants, particularly nortriptyline, continue to be commonly utilized, probably because of their affordability, the comfort level of physicians with these medications, and their diverse treatment use cases within limited resource settings. The findings underscore the necessity for enhanced prescribing guidelines, more comprehensive education for physicians, improved referral processes to psychiatric specialists, and focused monitoring of high-use demographics, particularly women and adults in Iran.
Abbreviations
- IHIO:
-
Iran Health Insurance Organization
- SSO:
-
Social Security Organization
- ATC:
-
Anatomical therapeutic chemical
- SSRI:
-
Selective serotonin reuptake inhibitor
- TCA:
-
Tricyclic antidepressant
- SNRI:
-
Serotonin–norepinephrine reuptake inhibitor
- NDRI:
-
Norepinephrine and dopamine reuptake inhibitor
- SARI:
-
Serotonin antagonist and reuptake inhibitor
- TeCA:
-
Tetracyclic antidepressant
- MAOI:
-
Monoamine oxidase inhibitor
Acknowledgements
We would like to express our gratitude to the social security organization and the Iran Health Insurance Organization for their kind assistance in providing the necessary data for our research.
Statement
Despite the fact that authors have made use of advanced large language models (LLMs) such as ChatGPT, Copilot (Bing AI), and a writing platform (Quill Bot) to help assess linguistic quality and assist in the utilization of data analysis software such as Excel and SPSS, it was ultimately the authors who conducted the analysis and interpretation of the results.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
Ehsan Aghajani, Sohrab Gharakhanlou, Mostafa Farahbakhsh, Ali Fakhari, Mahsa Matinkia & Mahdieh Taiyebkhosroshahi
Tabriz University of Medical Sciences, Tabriz, Iran
Ehsan Aghajani, Mostafa Farahbakhsh, Ali Fakhari, Ali Azimian & Mahsa Matinkia
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
Ali Azimian
Authors
- Ehsan Aghajani
- Sohrab Gharakhanlou
- Mostafa Farahbakhsh
- Ali Fakhari
- Ali Azimian
- Mahsa Matinkia
- Mahdieh Taiyebkhosroshahi
Corresponding author
Correspondence to Mahdieh Taiyebkhosroshahi.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval and consent to participate
This study was approved by the Research Ethics Committee of Tabriz University of Medical Sciences (ethical approval code: IR.TBZMED.REC.1402.284; publicly accessible at https://ethics.research.ac.ir/IR.TBZMED.REC.1402.284). As this was an anonymous, retrospective database study involving no direct contact with participants, the Research Ethics Committee of Tabriz University of Medical Sciences waived the requirement for individual informed consent. The use of insured individuals’ medical information for research purposes in this context is permitted under Iranian social security insurance legislation. All methods were performed in accordance with the relevant guidelines and regulations, including the Declaration of Helsinki.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Aghajani, E., Gharakhanlou, S., Farahbakhsh, M. et al. Real-world antidepressant prescribing patterns in outpatient care: a cross-sectional analysis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-74832-6
Received: 06 June 2026
Accepted: 01 October 2026
Published: 05 October 2026
DOI: https://doi.org/10.1038/s41598-026-74832-6
Keywords
来源:Nature 健康护理主题 · nature.com